NCT03522155

Patient-Centered Communication of Life Expectancy Estimates in Genitourinary Malignancies

Trial number:: NCT03522155

Trial phase:: N/A

Study type:: Supportive interventions, Observational

Overall status:: Recruiting

Study start date

September, 2021

Scientific title

A Patient-Centered Approach to Integration of Life Expectancy Into Treatment Decision Making for Patients With Genitourinary Malignancy

Summary

Investigators will conduct a randomized trial to determine if providing patient-specific life expectancy estimates during treatment counseling via a targeted, patient-centered communication approach improves shared decision making and reduces rates of overtreatment of genitourinary malignancies.

Inclusion criteria

Exclusion criteria

- Newly diagnosed clinical T1-2 prostate adenocarcinoma with Gleason scores of 7 or less - Newly diagnosed clinical T1a kidney cancer or renal masses < 4cm - Newly diagnosed clinical T2 nonmetastatic urothelial carcinoma of the bladder

- Under 18 years of age - Subjects with difficulty communicating or dementia - Non-English speakers

Study design

Primary purpose: Health Services Research, Allocation: Randomized, Intervention model: Parallel Assignment, Intervention model description: This randomized controlled trial will involve two arms, Masking: None (Open Label),

Conditions

Prostate Cancer Stage I, Prostate Cancer Stage II, Bladder Cancer Stage II, Kidney Cancer Stage I

Other study ID numbers

Pro00052777